03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Every day in the United States, 130 people die from opioid overdoses. To date, the opioid epidemic, ...
Read More >
The question of whether an arbitration clause has been successfully incorporated into a contract is ...
Read More >
Employers in Puerto Rico Precluded from Using Credit Reports or Credit History for Employment Action...
Read More >
The Department of Labor recently issued an opinion letter with respect to a situation that does not ...
Read More >
The Supreme Court of the United States kicked off its 2019-2020 term on October 7, 2019, with severa...
Read More >
USCIS Officially Releases Regulations Regarding Its H-1B Electronic Registration Tool for the FY 202...
Read More >